NAFTIDROFURYL USE IN MODERATE VASCULAR COGNITIVE DISORDERS
https://doi.org/10.21518/2079-701X-2017-0-22-26
Abstract
About the Authors
V. A. ParfenovRussian Federation
MD, Prof.
A. B. Lokshina
Russian Federation
PhD in medicine
D. A. Grishina
Russian Federation
PhD in medicine
Y. A. Starchina
Russian Federation
PhD in medicine
O. V. Kosivtsova
Russian Federation
References
1. Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebro vascular disease and dementia. Edited by O’Brien J, Ames D, Gustafson L et al. Martin Dunitz, 2004.
2. Яхно Н.Н. Когнитивные расстройства в неврологической клинике. Неврологический журнал, 2006, 11(1): 4-12.
3. Яхно Н.Н., Захаров В.В., Локшина А.Б., Коберская Н.Н., Мхитарян Э.А. Деменции. Руководство для врачей. М.: МедПресс-информ, 2011.
4. Парфенов В.А., Захаров В.В., Преображенская И.С. Когнитивные расстройства. М.: Ремедиум, 2014.
5. Gorelick PB, Scuteri A, Black SE et al. Vascular Contributions to Cognitive Impairment and De -men tia: A Statement for Healthcare Professio nals From the American Heart Association/Ame rican Stroke Association. Stroke, 2011, 42: 2672-2713.
6. Levine DA, Langa KM. Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications. Neurotherapeutics, 2011, 8: 361-373.
7. Sachdev P, Kalaria R, O’Brien J et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord, 2014, 28(3): 206-218.
8. Heiss W-D, Rosenberg GA, Thiel A. Neuro-imaging in vascular cognitive impairment: a state-of-the-art review. BMC Med, 2016, 14: 174.
9. Неверовский Д.В., Случевская С.Ф., Парфенов В.А. Дифференциальный диагноз дисциркуляторной энцефалопатии в амбулаторной практике. Неврология, нейропсихиатрия и психосоматика, 2013, 2: 38-42.
10. de Backer TL, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudi-cation. Cochrane Database Syst Rev, 2012 Dec 12, 12: CD001368.
11. Marcial JM, Pérez R, Vargas P, Franqui-Rivera H. Non-Invasive Therapy of Peripheral Arterial Disease. Bol Asoc Med P R, 2015, 107: 52-57.
12. Bouvier B, Passeron O, Chupín M. Psychometric Study of Praxilene. J Μ Med Res, 1974, 2: 59-62.
13. Saldmann F, Funel A, Jacquet P Efficacy of naftidrofuryl in patients with moderate senile dementia. Curr Med Res Opin, 1991, 12: 379-389.
14. Emeriau JP, Lehert P, Mosnier M. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results ofa multicenter, double-blind trial. ClinTher, 2000, 22: 834-844.
15. Möller H, Hartmann A, Kessler C et al. Naftidrofuryl in the treatment of vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci, 2001, 251: 247-54.
16. Lu D, Song H, Hao Z, Wu T, McCleery J. Naftidrofuryl for dementia. The Cochrane Library, 2011, Dec 7(12): CD002955.
17. Petersen RS, Touchon J. Consensus on mild cognitive impairment. Research and practice in Alzheimer’s disease. E.A.D.C.–A.D.C.S. Joint meeting, 2005, 10: 24-32.
18. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 2005, 53(4): 695-699.
19. Lezak MD ed. Neuropsychology Asessment. New York: New York University Press, 1983.
20. Белова А.Н., Шакурова Д.Н., Гаязова Е.В. Нафтидрофурил в терапии цереброваскулярных заболеваний: обзор литературы и собственные наблюдения. Неврология, нейропсихиатрия и психосоматика, 2014, 4: 110-115.
21. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol. Psychiatry, 2006, 60: 1304-1305.
22. Spinelli C, De Caro MF, Schirosi G et al. Impaired Cognitive Executive Dysfunction in Adult Treated Hypertensives with a Confirmed Diagnosis of Poorly Controlled Blood Pressure. Int. J. Med. Sci., 2014, 11: 771-778.
23. Tadic M, Cuspidi C, Hering D. Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord, 2016, 16: 208.
Review
For citations:
Parfenov VA, Lokshina AB, Grishina DA, Starchina YA, Kosivtsova OV. NAFTIDROFURYL USE IN MODERATE VASCULAR COGNITIVE DISORDERS. Meditsinskiy sovet = Medical Council. 2017;(1S):22-26. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-22-26